Glenmark Pharmaceuticals reports 9-fold jump in Q1 consolidated net profit

16 Aug 2024 Evaluate

Glenmark Pharmaceuticals has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 67.02% rise in net profit at Rs 453.73 crore for Q1FY25 as compared to Rs 271.66 crore for the same quarter in the previous year. Total income of the company increased by 8.73% at Rs 2385.19 crore for Q1FY25 as compared to Rs 2193.75 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 9- fold jump in its net profit at Rs 340.24 crore for the quarter ended June 30, 2024 as compared to Rs 37.68 crore for the same quarter in the previous year. Total income of the company increased by 7.20% at Rs 3275.68 crore for Q1FY25 as compared to Rs 3055.79 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1465.30 -27.05 (-1.81%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.